RhumbLine Advisers’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.04M | Sell |
|
|||||
|
2025
Q1 | $3.12M | Sell |
|
|||||
|
2024
Q4 | $5.24M | Sell |
|
|||||
|
2024
Q3 | $8.26M | Buy |
|
|||||
|
2024
Q2 | $6.75M | Sell |
|
|||||
|
2024
Q1 | $11.8M | Buy |
|
|||||
|
2023
Q4 | $2.4M | Sell |
|
|||||
|
2023
Q3 | $1.45M | Buy |
|
|||||
|
2023
Q2 | $2.07M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $277K | Sell |
|
|||||
|
2021
Q4 | $501K | Sell |
|
|||||
|
2021
Q3 | $688K | Buy |
|
|||||
|
2021
Q2 | $636K | Sell |
|
|||||
|
2021
Q1 | $726K | Sell |
|
|||||
|
2020
Q4 | $677K | Buy |
|
|||||
|
2020
Q3 | $621K | Sell |
|
|||||
|
2020
Q2 | $871K | Buy |
|
|||||
|
2020
Q1 | $512K | Buy |
|
|||||
|
2019
Q4 | $807K | Buy |
|
|||||
|
2019
Q3 | $685K | Buy |
|
|||||
|
2019
Q2 | $762K | Buy |
|
|||||
|
2019
Q1 | $773K | Buy |
|
|||||
|
2018
Q4 | $556K | Buy |
|
|||||
|
2018
Q3 | $783K | Buy |
|
|||||
|
2018
Q2 | $395K | Buy |
|